Mid-Year Epidemiological Profile of COVID-19 Posi ve Cases in Rajasthan, India

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 15 | Issue : 03 | Page :
    By

    Deepa Meena,

  • Praveen Aswal,

  • Mukesh Vijayvergia,

  • Yashika Jain,

  • Amaya Vaze,

  1. EISO & State Epidemiologist, Directorate of Medical & Health Services, Rajasthan, India
  2. Additional Director (Rural Health), Directorate of Medical & Health Services, Rajasthan, India
  3. Joint Director, Disaster Management, Directorate of Medical & Health Services, Rajasthan, India
  4. Intern, Department of Public Health, Amity University, Pune, India
  5. Public Health Consultant, Independent Consultant, , India

Abstract

Background: COVID-19, caused by SARS-CoV-2, has posed persistent public health challenges globally since its emergence in late 2019. India, through enhanced surveillance and vaccina on, has seen a progressive decline in case burden. Despite improvements, localized surges and emerging variants necessitate con nuous monitoring. Rajasthan, with its urban-rural health dispari es, experienced a modest resurgence of cases in early 2025, raising concerns about exis ng immunity gaps and health system stress. This study aims to describe the epidemiology of COVID-19 posi ve cases in Rajasthan during January to June 2025 and assess trends in hospitaliza on, mortality, and comorbidi es. Method: A cross-sec onal study design was used. Data from January to June 2025 were obtained from IDSP, hospitals, and tes ng laboratories across Rajasthan. Variables included age, sex, loca on, diagnosis date, hospitaliza on, comorbidity, and outcomes. Data were cleaned and analyzed using descrip ve sta s cs. Geospa al and me-trend analyses were conducted using Excel. Ethical permissions were secured, with no iden fiable pa ent data used. Results: A total of 427 cases were reported, with 66% from Jaipur. Median age was 44 years; 79.9% resided in urban areas; and 57% were male. Hospitaliza on was required for 15% of cases, primarily at ter ary centers. Comorbidi es were present in 11.7% of cases, with diabetes and hypertension most common. Two deaths were reported (CFR = 0.46%) one in a 26-yearold with tuberculosis and another in a 52-year-old without known comorbidi es. A significant case surge occurred in June, accompanied by increased tes ng rates.
Conclusion: The resurgence of COVID-19 in Rajasthan during mid-2025, par cularly in urban hubs like Jaipur, highlights the need for sustained surveillance, preparedness, and integra on of NCD and infec ous disease management. The demographic and clinical pa erns observed emphasize the ongoing risk to working-age adults and the necessity for localized public health strategies

Keywords: COVID-19, SARS-CoV-2, Epidemiology, Rajasthan, India, Resurgence, Hospitalization, Mortality, Comorbidities, Diabetes, Hypertension, Surveillance, Public Health, Urban-Rural Disparities

[This article belongs to Research and Reviews : A Journal of Immunology ]

How to cite this article:
Deepa Meena, Praveen Aswal, Mukesh Vijayvergia, Yashika Jain, Amaya Vaze. Mid-Year Epidemiological Profile of COVID-19 Posi ve Cases in Rajasthan, India. Research and Reviews : A Journal of Immunology. 2025; 15(03):-.
How to cite this URL:
Deepa Meena, Praveen Aswal, Mukesh Vijayvergia, Yashika Jain, Amaya Vaze. Mid-Year Epidemiological Profile of COVID-19 Posi ve Cases in Rajasthan, India. Research and Reviews : A Journal of Immunology. 2025; 15(03):-. Available from: https://journals.stmjournals.com/rrjoi/article=2025/view=231744


References

  1. World Health Organization. Living with COVID-19: strategic preparedness and response plan. Geneva: WHO; 2022. Available from: https://www.who.int/publications/i/item/WHO-WHE-SPP-2022.1
  2. Centers for Disease Control and Prevention. Underlying medical conditions are associated with higher risk for severe COVID-19. Atlanta: CDC; 2023. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
  3. World Bank. COVID-19 and health system resilience in South Asia. Washington, DC: World Bank; 2022. Available from: https://www.worldbank.org/en/topic/health/publication
  4. National Centre for Disease Control. Integrated Disease Surveillance Programme: annual report. New Delhi: NCDC; 2024.
  5. Rajasthan Medical Services Corporation. COVID-19 hospital readiness report. Jaipur: Government of Rajasthan; 2024.
  6. Indian Council of Medical Research. ICMR bulletin on COVID-19 surveillance in India. New Delhi: ICMR; 2024.
  7. Gavi, The Vaccine Alliance. India’s COVID-19 vaccination campaign overview. Geneva: Gavi; 2023 [cited 2025 Sep 12]. Available from: https://www.gavi.org/vaccineswork/indias-covid-19-vaccine-campaign
  8. Underreporting in India’s COVID-19 surveillance data. Mumbai: IndiaSpend; 2023 [cited 2025 Sep 12]. Available from: https://www.indiaspend.com
  9. Kaur H, Mishra S. COVID-19 surveillance challenges in India. Int J Community Med Public Health. 2023;10(1):52–7. doi:10.18203/2394-6040.ijcmph20223567
  10. Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941–50. doi:10.1016/S0140-6736(17)30003-X
  11. Sharma V, Aggarwal D. Public health response to COVID-19 in Indian states. BMJ Glob Health. 2023;8(2):e009123. doi:10.1136/bmjgh-2022-009123
  12. World Health Organization. WHO coronavirus (COVID-19) dashboard. Geneva: WHO; 2023 [cited 2025 Sep 12]. Available from: https://covid19.who.int
  13. Ministry of Health and Family Welfare. COVID-19 India dashboard. New Delhi: Government of India; 2024 [cited 2025 Sep 12]. Available from: https://www.mohfw.gov.in
  14. Government of Rajasthan, Department of Medical & Health Services. COVID-19 weekly bulletin: January–December 2024. Jaipur: Government of Rajasthan; 2024.
  15. Bhargava R, Jain H. Urban-rural differences in COVID-19 outcomes in India. J Glob Health. 2022; 12:045001. doi:10.7189/jogh.12.045001
  16. Government of Rajasthan, Department of Medical & Health Services. COVID-19 weekly bulletin: January–June 2025. Jaipur: Government of Rajasthan; 2025.
  17. Government of Rajasthan. Rajasthan economic review 2023–24: health and medical services chapter. Jaipur: Government of Rajasthan; 2024.
  18. Dasgupta P, Sahu P. COVID-19, comorbidities, and health system capacity in India. Health Policy Plan. 2021;36(9):1306–12. doi:10.1093/heapol/czab087
  19. Gupta A, Verma N. Comorbidities and COVID-19 mortality in India: a meta-analysis. Indian J Med Res. 2021;153(6):799–807. doi: 10.4103/ijmr.IJMR_2879_21
  20. United Nations Development Programme (India). COVID-19 socio-economic impact assessment in India. New Delhi: UNDP; 2023 [cited 2025 Sep 12]. Available from: https://www.undp.org/india/publications
  21. World Health Organization, South-East Asia Regional Office. Strengthening health systems post-COVID in South-East Asia. New Delhi: WHO SEARO; 2023 [cited 2025 Sep 12]. Available from: https://www.who.int/southeastasia
Regular Issue Subscription Original Research
Volume 15
Issue 03
Received 30/08/2025
Accepted 13/09/2025
Published 13/11/2025
Publication Time 75 Days
130

Login


My IP

PlumX Metrics